sugammadex 500 MG in 5 ML Injection
- RxCUI
- 1727000
- RxNorm name
- sugammadex 500 MG in 5 ML Injection
- Display name
- sugammadex 500 MG in 5 ML Injection
- Full name
- sugammadex 500 MG in 5 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:58
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sugammadex | SUGAMMADEX | Zydus Pharmaceuticals USA Inc. | 21028965-598b-4cfa-a614-5c28ed40306a | 2026-07-02 | Warnings, Adverse reactions | 1727000 |
| Sugammadex | SUGAMMADEX | Zydus Lifesciences Limited | b1ec2b5e-a571-4511-ab44-d4193441330a | 2026-07-02 | 1727000 | |
| BRIDION | SUGAMMADEX | Merck Sharp & Dohme LLC | 5171d883-fe8f-482c-97ab-40b00975b64a | 2026-03-13 | Warnings, Adverse reactions | 1727000 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5171d883-fe8f-482c-97ab-40b00975b64a | sugammadex 500 MG in 5 ML Injection | PSN | 26 | These highlights do not include all the information needed to use BRIDION safely and effectively. See full prescribing information for BRIDION. BRIDION ® (sugammadex) Injection, for intravenous use Initial U.S. Approval: 2015 | 20260313 |
| 5171d883-fe8f-482c-97ab-40b00975b64a | sugammadex 500 MG per 5 ML Injection | SY | 26 | These highlights do not include all the information needed to use BRIDION safely and effectively. See full prescribing information for BRIDION. BRIDION ® (sugammadex) Injection, for intravenous use Initial U.S. Approval: 2015 | 20260313 |
| 5171d883-fe8f-482c-97ab-40b00975b64a | 5 ML sugammadex 100 MG/ML Injection | SCD | 26 | These highlights do not include all the information needed to use BRIDION safely and effectively. See full prescribing information for BRIDION. BRIDION ® (sugammadex) Injection, for intravenous use Initial U.S. Approval: 2015 | 20260313 |